COMPPARE Reaches Institutional Milestone

The COMPPARE Coordinating Center is very pleased to announce the activation of all 45 original targeted study sites.

The UH Seidman Cancer Center was welcomed on June 1, 2020, for a total 12 new sites and principal investigators added to the team:

  • UH Seidman Cancer Center, Cleveland, OH
  • Cleveland Clinic, Cleveland, OH
  • University of Arizona, Tucson, AZ
  • Sutter Health, Sacramento, CA
  • Johns Hopkins University, Baltimore, MD
  • Duke University, Durham, NC
  • University of Virginia Health System, Charlottesville, VA
  • University of Kansas, Lawrence, KS
  • Weill Cornell Medicine, NYC
  • Oregon Health & Science University, Portland, OR
  • University of Alabama at Birmingham, Birmingham, AL
  • University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, OK

These institutions will work with the University of Florida to enroll photon and proton patients on COMPPARE.